{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:05:58Z","timestamp":1790287558958,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omtm.2025.101457","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T05:09:11Z","timestamp":1743138551000},"page":"101457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Ionizable lipid nanoparticles with functionalized PEG-lipids increase retention in the tumor microenvironment"],"prefix":"10.1016","volume":"33","author":[{"given":"Matthew","family":"Jester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Haley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"Billingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Figueroa-Espada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryann A.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-2244","authenticated-orcid":false,"given":"Michael J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101457_bib1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.omtm.2025.101457_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/or.2023.10577","article-title":"Challenges and Opportunities Associated With Drug Delivery for the Treatment of Solid Tumors","volume":"17","author":"Paresishvili","year":"2023","journal-title":"Oncol. Rev."},{"key":"10.1016\/j.omtm.2025.101457_bib3","article-title":"Emerging Technologies for Local Cancer Treatment","volume":"3","author":"Chua","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.omtm.2025.101457_bib4","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.apsb.2022.07.011","article-title":"Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy","volume":"13","author":"Butowska","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.omtm.2025.101457_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.omtm.2025.101457_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtm.2025.101457_bib7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.omtm.2025.101457_bib8","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/jpm11060571","article-title":"Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment","volume":"11","author":"Subhan","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.omtm.2025.101457_bib9","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.232654","article-title":"Intratumoral Injection of Immunotherapeutics: State of the Art and Future Directions","volume":"312","author":"Sheth","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.omtm.2025.101457_bib10","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1039\/D0TB00649A","article-title":"Overcoming the biological barriers in the tumor microenvironment for improving drug delivery and efficacy","volume":"8","author":"Zhou","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.omtm.2025.101457_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-chembioeng-061010-114300","article-title":"Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies","volume":"2","author":"Chauhan","year":"2011","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"10.1016\/j.omtm.2025.101457_bib12","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMc2101667","article-title":"Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine","volume":"384","author":"Krammer","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtm.2025.101457_bib13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41541-023-00751-6","article-title":"Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability","volume":"8","author":"Zhang","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.omtm.2025.101457_bib14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03275-y","article-title":"BNT162b vaccines protect rhesus macaques from SARS-CoV-2","volume":"592","author":"Vogel","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101457_bib15","article-title":"Solid lipid nanoparticles: An effective lipid-based technology for cancer treatment","volume":"86","author":"Akanda","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.omtm.2025.101457_bib16","doi-asserted-by":"crossref","first-page":"165981","DOI":"10.1155\/2013\/165981","article-title":"Lipid-Based Nanoparticles in Cancer Diagnosis and Therapy","volume":"2013","author":"Miller","year":"2013","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.omtm.2025.101457_bib17","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.apsb.2022.04.013","article-title":"Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.omtm.2025.101457_bib18","doi-asserted-by":"crossref","first-page":"21877","DOI":"10.1021\/acsami.3c01501","article-title":"Lipid Nanoparticle Delivery of Small Proteins for Potent In Vivo RAS Inhibition","volume":"15","author":"Haley","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.omtm.2025.101457_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s43586-023-00246-7","article-title":"Nanotechnology-based mRNA vaccines","volume":"3","author":"Chen","year":"2023","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.omtm.2025.101457_bib20","article-title":"Application of lipid-based nanoparticles in cancer immunotherapy","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2025.101457_bib21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1021\/acsnanoscienceau.2c00062","article-title":"Recent Advances in Site-Specific Lipid Nanoparticles for mRNA Delivery","volume":"3","author":"Xu","year":"2023","journal-title":"ACS Nanosci. Au"},{"key":"10.1016\/j.omtm.2025.101457_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3390\/pharmaceutics15010216","article-title":"Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy","volume":"15","author":"Marques","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtm.2025.101457_bib23","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1039\/D3NA00198A","article-title":"Strategies for targeted gene delivery using lipid nanoparticles and cell-derived nanovesicles","volume":"5","author":"Lee","year":"2023","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.omtm.2025.101457_bib24","first-page":"337","article-title":"PEGylation in anti-cancer therapy: An overview","volume":"11","author":"Mishra","year":"2016","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.omtm.2025.101457_bib25","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/s41591-022-02061-1","article-title":"The landscape of mRNA nanomedicine","volume":"28","author":"Huang","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2025.101457_bib26","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0169-409X(03)00108-X","article-title":"Pharmacokinetic and biodistribution properties of poly(ethylene glycol)\u2013protein conjugates","volume":"55","author":"Caliceti","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtm.2025.101457_bib27","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2025.101457_bib28","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.omtm.2025.101457_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2022.100917","article-title":"Folate Receptor as a Biomarker and Therapeutic Target in Solid Tumors","volume":"47","author":"Young","year":"2023","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.omtm.2025.101457_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13046-019-1123-1","article-title":"Folate receptors and transporters: biological role and diagnostic\/therapeutic targets in cancer and other diseases","volume":"38","author":"Frigerio","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.omtm.2025.101457_bib31","article-title":"Cellular Uptake and Antitumor Activity of DOX-hyd-PEG-FA Nanoparticles","volume":"9","author":"Ye","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2025.101457_bib32","doi-asserted-by":"crossref","first-page":"e2304378","DOI":"10.1002\/smll.202304378","article-title":"In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism","volume":"20","author":"Billingsley","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.omtm.2025.101457_bib33","doi-asserted-by":"crossref","first-page":"e2313226","DOI":"10.1002\/adma.202313226","article-title":"Antigen Presenting Cell Mimetic Lipid Nanoparticles for Rapid mRNA CAR T Cell Cancer Immunotherapy","volume":"36","author":"Metzloff","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omtm.2025.101457_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.carbpol.2017.07.076","article-title":"Alginate modified with maleimide-terminated PEG as drug carriers with enhanced mucoadhesion","volume":"175","author":"Shtenberg","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.omtm.2025.101457_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122187","article-title":"Maleimide as the PEG end-group promotes macrophage-targeted drug delivery of PEGylated nanoparticles in vivo by enhancing interaction with circulating erythrocytes","volume":"300","author":"Wang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtm.2025.101457_bib36","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1021\/acscentsci.3c00177","article-title":"Thiol-Mediated Uptake of a Cysteine-Containing Nanobody for Anticancer Drug Delivery","volume":"9","author":"Goerdeler","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.omtm.2025.101457_bib37","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1073\/pnas.2628032100","article-title":"Lymphocyte surface thiol levels","volume":"100","author":"Sahaf","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101457_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41419-017-0061-0","article-title":"Defining the role of the tumor vasculature in antitumor immunity and immunotherapy","volume":"9","author":"Schaaf","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omtm.2025.101457_bib39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2016.06.116","article-title":"Determination of the activity of maleimide-functionalized phospholipids during preparation of liposomes","volume":"514","author":"Oswald","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.omtm.2025.101457_bib40","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1021\/mp9000124","article-title":"Synthesis and Biological Evaluation of a Bioresponsive and Endosomolytic siRNA\u2212Polymer Conjugate","volume":"6","author":"Meyer","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omtm.2025.101457_bib41","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3762\/bjoc.11.82","article-title":"Probing multivalency in ligand\u2013receptor-mediated adhesion of soft, biomimetic interfaces","volume":"11","author":"Schmidt","year":"2015","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.omtm.2025.101457_bib42","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/27\/30\/305603","article-title":"Functionalization of emissive conjugated polymer nanoparticles by coprecipitation: consequences for particle photophysics and colloidal properties","volume":"27","author":"Singh","year":"2016","journal-title":"Nanotechnology"},{"key":"10.1016\/j.omtm.2025.101457_bib43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/RLI.0b013e3182034fed","article-title":"Ultrasound Molecular Imaging of Tumor Angiogenesis With an Integrin Targeted Microbubble Contrast Agent","volume":"46","author":"Anderson","year":"2011","journal-title":"Investig. Radiol."},{"key":"10.1016\/j.omtm.2025.101457_bib44","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.omtm.2025.101457_bib45","doi-asserted-by":"crossref","first-page":"e1805308","DOI":"10.1002\/adma.201805308","article-title":"Dendrimer-Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I","volume":"30","author":"Cheng","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omtm.2025.101457_bib46","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1021\/acs.nanolett.8b01101","article-title":"Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA","volume":"18","author":"Ball","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.omtm.2025.101457_bib47","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/s41565-021-00928-x","article-title":"Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics","volume":"16","author":"Dammes","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtm.2025.101457_bib48","doi-asserted-by":"crossref","first-page":"191","DOI":"10.18433\/jpps30318","article-title":"Drug Targeting Strategies Based on Charge Dependent Uptake of Nanoparticles into Cancer Cells","volume":"22","author":"Saadat","year":"2019","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.omtm.2025.101457_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jconrel.2018.03.002","article-title":"Insights into maleimide-thiol conjugation chemistry: Conditions for efficient surface functionalization of nanoparticles for receptor targeting","volume":"282","author":"Mart\u00ednez-Jothar","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.omtm.2025.101457_bib50","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1021\/acs.nanolett.1c01353","article-title":"Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device","volume":"21","author":"Shepherd","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.omtm.2025.101457_bib51","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1021\/acs.nanolett.9b04246","article-title":"Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering","volume":"20","author":"Billingsley","year":"2020","journal-title":"Nano Lett."}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905012500052X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905012500052X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T18:50:21Z","timestamp":1759863021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S232905012500052X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S232905012500052X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101457","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ionizable lipid nanoparticles with functionalized PEG-lipids increase retention in the tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101457"}}